United States · Funded startup

Who invested in Atreca

6 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$313Mraised across 6 rounds since 2011, from 6 sources

$160KDebt$6.0MVenture$700KDebt$56MSeries A$125MSeries C$125MRound
Latest round
Round, $125MJul 2020
Investors
14
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2013201520172019
$160KDebt$6.0MVenture$700KDebt$56MSeries A$125MSeries C$125MRound
First round
Debt, $160K
Oct 2011
Biggest round
$125M
Round · Jul 2020
Usual gap between rounds
21 months
the median of 5

The rounds

  1. Jul 2020
  2. Sept 2018
    Series C$125M8 new

    Reported by FinSMEsSEC filing: $125M sold, first sale Sept 2018

  3. Nov 2015
    Series A$56M2 new1 returning

    From a historical funding recordSEC filing: $57M sold, first sale Aug 2015

  4. Aug 2013
    Debt$700K

    No investor was named in the report.

    Reported by sec.govSEC filing: $700K sold, first sale Aug 2013

  5. Sept 2012
    Venture$6.0M2 new

    Reported by finsmes.comSEC filing: $350K sold, first sale Feb 2012

  6. Oct 2011
    Debt$160K

    No investor was named in the report.

    Reported by sec.govSEC filing: $160K sold, first sale Mar 2011

Founders and team

From the SEC filings it signed: 3 on the team.

  • John OrwinExecutive Officer, Directori
  • Susan BerlandExecutive Officeri
  • Tito SerafiniExecutive Officer, Directori

On the board, as filediBrian AtwoodDavid LaceyFranklin BergerLawrence SteinmanWilliam Robinson

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Wellington ManagementVC firm2rounds
Redmile GroupVC firm2rounds
Gates FoundationInstitutional LP2rounds
Cormorant Asset ManagementPrivate equity1round
Samsara BioCapitalVC firm1round
EcoR1 CapitalPrivate equity1round
Cormorant CapitalVC firm1round
GlaxoSmithKlineVC firm1round
Mission Bay CapitalVC firm1round
Boxer CapitalVC firm1round
SamsaraHedge fund1round
Aislingno record of our own yet1round
Teklano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Atreca as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Aisling CapitalPrivate equityPer its own site
Mission BioCapitalVC firmPer its own site
HCL CapitalFamily officePer its own site

Quick answers about Atreca

Who invested in Atreca?

Atreca's investors include Wellington Management, Redmile Group, Gates Foundation, Cormorant Asset Management and Samsara BioCapital, and 9 more on record.

How much has Atreca raised?

Atreca has raised $313M across 6 rounds since 2011.

When did Atreca last raise?

Atreca's most recent round was an Undisclosed round of $125M in Jul 2020.

What was Atreca's biggest round?

Its most recent round, $125M in Jul 2020, is also its largest on record.

Who backed Atreca first?

Atreca's first round on record, in Sept 2012, was backed by Gates Foundation and The Bill & Melinda Gates Foundation.

What stage is Atreca at?

Atreca's latest named round is an Undisclosed round, in Jul 2020.

Where is Atreca based?

Atreca is based in the United States.

Companies like Atreca

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.